https://rjrindex.com/articles/primary-care-pcp-and-oncology-onc-provider-perspectives-on-primary-care-involvement-in-cancer-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-pediatric-and-adolescent-thyroid-carcinoma-incidence-and-survival-in-the-united-states-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-fruquintinib-plus-trifluridinetipiracil-in-refractory-metastatic-colorectal-cancer-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-appendiceal-cancer-mortality-in-the-united-states-from-1999-to-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-clinical-outcomes-with-lenvatinib-versus-cabozantinib-post-progression-on-first-line-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cv-care-cardiovascular-care-of-androgen-related-effects-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridge-barriers-to-real-world-implementation-of-diagnostic-genomics-quantifying-the-genomic-awarene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expert-perspectives-in-the-management-of-myelofibrosis-mf-a-survey-of-20-us-based-specialists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-impacting-survival-in-malignant-pheochromocytoma-a-population-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indocyanine-green-guided-lymphadenectomy-in-gastrectomy-for-gastric-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iparomlimab-and-tuvonralimab-combined-with-paclitaxel-and-cisplatin-as-neoadjuvant-therapy-for-cervi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scintmatch-a-probabilistic-soft-matching-framework-for-integrating-single-cell-genomes-and-transcri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-open-label-study-of-pasritamig-jnj-78278343-a-t-cell-engager-targeting-huma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-phase-ii-study-of-chemotherapy-sox-plus-tislelizumab-as-first-line-therapy-for-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polypharmacy-discussions-in-older-adults-with-newly-diagnosed-acute-myeloid-leukemia-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-for-identification-of-distinct-tolerance-phenotypes-with-differential-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-transarterial-chemoembolization-combined-with-apatinib-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-era-01cleap2507-a-multi-center-single-arm-phase-ii-study-with-neoadjuvant-therapy-of-haic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-high-claudin-18-expression-in-gallbladder-cancer-and-association-with-survival-implic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-disparities-in-hepatocellular-carcinoma-incidence-in-the-united-states-2001-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-gastric-cancer-incidence-by-age-and-sex-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-fertility-preservation-and-pregnancy-after-treatment-in-young-patients-with-brca-associat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-implantable-central-venous-access-devices-chemoports-in-patients-with-malign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronotherapy-in-metastatic-melanoma-retrospective-outcomes-of-immunotherapy-administration-timing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-demographic-patterns-of-mucosal-lentiginous-melanoma-a-retrospective-ncdb-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-prostate-cancer-and-heart-failure-hospitalizations-an-intersection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adenocarcinoma-with-cartilaginous-and-osseous-metaplasia-a-study-of-demographic-and-socioeconomic-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-disaster-strikes-a-scoping-review-of-climate-resilience-toolkits-relevant-to-cancer-care-deliv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-breast-cancer-incidence-mortality-and-disability-adjusted-life-years-in-europe-1990-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-care-events-after-outpatient-systemic-therapy-among-patients-at-elevated-risk-for-acute-care-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iccnd1i-amplification-and-breast-cancer-specific-survival-in-estrogen-recep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-as-a-surrogate-mortality-and-vascular-risk-in-gastrointestinal-stromal-tumor-after-frailty-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limitations-in-us-cancer-screening-rate-data-and-opportunities-for-improvement 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-melanoma-of-unknown-versus-known-primary-receiving-immunotherapy-a-systemic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-malignant-melanoma-in-the-african-union-from-1980-2023-insights-from-the-gbd-2023-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-chemotherapy-induced-neuropathy-and-gabapentin-exposure-among-adults-receiving-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-causes-and-predictors-of-inpatient-mortality-among-cancer-patients-in-a-tertiary-center-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-translational-approach-for-in-vitro-monitoring-of-patient-derived-tumor-organoid-responses-to-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-specific-risk-of-mood-and-anxiety-disorders-following-cancer-diagnosis-in-adolescents-and-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-plus-immunotherapy-versus-chemotherapy-immunotherapy-in-pd-l1-positive-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disrupting-the-microbiome-disrupting-immunity-antibiotic-exposure-and-survival-outcomes-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pucotenlimab-plus-dose-intensified-radiotherapy-and-chemotherapy-for-locally-advanced-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-the-silence-sexual-quality-of-life-in-moroccan-women-after-gestational-trophoblastic-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-atezolizumabbevacizumab-vs-durvalumabtremelimumab-in-decompensated-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-body-mass-index-bmi-impact-in-advanced-cholangiocarcinoma-cca-treated-with-chemo-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-remodeling-of-the-tumor-immune-microenvironment-time-on-neoadjuvant-chemo-immunotherapy-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-mortality-among-adults-younger-than-55-years-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-petct-guided-intensification-of-salvage-radiotherapy-versus-conventional-planning-for-biochemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-adverse-events-associated-with-epidermal-growth-factor-receptor-inhibitor-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-postoperative-antibiotic-prophylaxis-after-radical-cystectomy-interim-results-of-the-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-heart-failure-in-breast-cancer-patients-receiving-her2-directed-therapy-a-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-the-epidemiology-and-long-term-outcomes-of-early-onset-luminal-b-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-population-specific-ikrasi-alterations-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-from-pulmonary-embolism-among-patients-with-lung-and-bronchus-malignancies-national-trend 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-mortality-burden-of-primary-brain-malignancies-versus-brain-metastases-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leptomeningeal-disease-in-alk-positive-nsclc-survival-impact-of-third-generation-alk-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/galeterone-and-gemcitabine-in-advanced-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-national-burden-of-pancreatic-cancer-in-the-united-states-contemporary-real-world-tren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-efficacy-of-neuroendoscopic-resection-of-intraventricular-tumors-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adult-medulloblastoma-long-term-follow-up-analysis-of-a-single-center-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-lightweight-deep-learning-for-glioma-detection-mobilenet-based-mri-classification-to-enable-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-renal-cell-carcinoma-outcomes-the-paradigm-shift-influenced-by-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-first-in-human-study-of-skb500-in-patients-with-locally-advanced-or-metastatic-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-hypofractionation-stereotactic-body-radiotherapy-metastatic-radiotherapy-utilization-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-resident-education-in-ambulatory-oncology-a-novel-flipped-classroom-curriculum-for-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-macroeconomic-burden-of-tobacco-attributable-cancers-in-2023-global-disparities-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/embark-testosterone-recovery-to-gt250-ngdl-following-treatment-suspension 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mosunetuzumab-plus-polatuzumab-vedotin-mosun-pola-versus-rituximab-gemcitabine-and-oxaliplatin-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-unsupervised-genetic-clustering-to-identify-biologically-distinct-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-pilot-study-of-aromatherapy-to-reduce-anxiety-and-pain-during-bone-marrow-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dimensional-multiplex-immunofluorescence-to-reveal-immune-microenvironment-remodeling-in-matche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-phase-operational-readiness-gaps-in-oncology-cell-and-gene-therapy-trials-and-implications-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-the-nccn-distress-thermometer-to-evaluate-clinically-elevated-levels-of-distress-among-caregiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-adc-biomarker-targets-in-endometrial-cancer-ec-molecular-characterizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-denosumab-treatment-strategies-to-balance-skeletal-related-events-for-prevention-and-oste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-daratumumab-carfilzomib-pomalidomide-and-dexamethasone-in-relapsedrefractory-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-head-to-head-comparison-of-sextant-systematic-biopsy-versus-extended-systematic-biopsy-for-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mixed-formulation-aprepitant-and-palonosetron-qlm2010-for-prevention-of-cis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-smoking-tumor-genetics-and-outcomes-in-men-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-nectin4-in-shaping-the-tumor-microenvironment-and-potentiating-the-efficacy-of-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-penpulimab-combined-with-taxanes-and-carboplatin-in-triple-negative-breast-cancer-updat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-immune-related-adverse-events-from-checkpoint-inhibitors-in-cancer-patients-with-autoimmune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-a-feasibility-and-safety-trial-of-tile-based-radiation-therapy-with-cesium-131-followed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-drug-industry-payments-to-oncologists-and-use-of-guideline-preferred-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-autoimmunity-meets-immunotherapy-immune-checkpoint-inhibitors-in-cancer-patients-with-rheumato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signatures-of-biological-heterogeneity-associated-with-treatment-outcome-in-diffuse-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-durvalumab-plus-neoadjuvant-chemoradiotherapy-cross-with-and-without-tremelimumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-brafmek-inhibition-in-ibrafi-supv600esup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-biliary-drainage-in-malignant-biliary-obstruction-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-in-combination-with-chemotherapy-in-resectable-locally-advanced-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-bmi-and-overall-survival-os-among-hispanic-patients-treated-with-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-generation-h1-antihistamine-use-with-survival-and-immune-related-outcomes-in-lung-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-with-nab-paclitaxel-and-cisplatin-versus-docetaxel-cisplatin-and-fluorourac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-oncogenic-protein-sequestration-by-platelets-on-early-and-stage-specific-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ikrasi-co-mutations-on-the-efficacy-of-durval 2026-08-24 monthly 0.7 https://rjrindex.com/articles/suicide-gene-therapy-for-recurrent-glioblastoma-using-allogeneic-bone-marrow-derived-mesenchymal-ste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-kinetics-and-practice-patterns-in-4-year-long-term-beneficiaries-of-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-venous-thromboembolism-in-lung-cancer-patients-treated-with-chemotherapy-versus-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-safety-of-autologous-fat-grafting-as-part-of-local-regional-management-of-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-safety-and-antitumor-activity-from-a-first-in-human-phase-1-study-of-awt020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualizing-first-line-treatment-choices-in-metastatic-urothelial-carcinoma-muc-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-epigenomic-profiling-for-identification-of-mechanisms-of-sensitivity-primary-and-acquired-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-clinical-trial-of-a-fasting-mimic-diet-prior-to-chemotherapy-to-evaluate-the-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/c-met-expression-by-ihc-and-response-to-cabozantinib-in-patients-with-relapsed-refractory-germ-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-rhamnose-derived-from-gut-microbiome-in-modulating-the-efficacy-of-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/costs-per-avoided-event-cpae-in-adjuvant-cdk46-inhibitor-therapy-a-comparative-analysis-of-subgr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-biological-and-immune-microenvironment-features-of-msi-h-braf-supv600 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-delta-like-ligand-3-dll3-expression-levels-and-characteristics-of-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-tumor-mutation-profiles-preoperative-circulating-tumor-dna-ctdna-and-clinical-featur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soluble-cd137-in-health-and-disease-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptional-correlates-of-iarnti-expression-and-its 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-anlotinib-in-patients-with-advanced-nsclc-refractory-to-prior-systemic-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disentangling-ikeap1i-and-istk11 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-therapy-in-patients-with-advanced-cancer-and-chronic-viral-infections-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-ki-67-index-and-histologic-grade-between-biopsy-and-surgical-specimens-in-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-of-gynecological-malignancies-in-india-as-associated-with-distinct-msi-and-histo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-clinical-and-genomic-landscape-of-bilateral-parenchymal-non-small-cell-lung-cancer-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-clinical-characteristics-of-women-lt-50-years-and-impact-on-adjuvant-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-ct-use-by-oncotype-dx-o-dx-recurrence-score-rs-in-hormone-receptor-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pkpd-and-efficacy-results-from-expand-1-a-phase-1-dose-escalation-study-of-the-novel-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-gut-microbiota-taxonomic-deviation-and-its-association-with-outcomes-and-toxici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-mortality-due-to-brain-metastases-secondary-to-lung-cancer-in-the-united-states-a-populat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vepdegestrant-a-proteolysis-targeting-chimera-protac-estrogen-receptor-er-degrader-plus-atirmo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-safety-of-oncoplastic-breast-conservation-surgery-experience-of-over-a-decade-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-autologous-tumor-infiltrating-lymphocytes-gt201-plus-toripalimab-in-recurrent-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-high-dose-chemotherapy-in-adult-patients-with-relapsed-or-refractory-medulloblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-brain-tumors-complicated-by-respiratory-failure-national-patterns-and-forecaste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/projected-trends-in-ischemic-heart-disease-mortality-among-patients-with-multiple-myeloma-in-the-uni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-characteristics-and-inpatient-outcomes-of-early-onset-pancreatic-cancer-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-outcomes-and-early-survival-after-curative-intent-non-small-cell-lung-cancer-nsclc-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/group-based-versus-individualized-exercise-programs-in-lung-cancer-results-from-the-randomized-cros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-multi-task-intraoperative-diagnosis-of-lung-cancer-via-deep-neural-network-driven-label-free-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-international-phase-iii-randomized-double-blind-double-dummy-trial-comparing-duloxetine-and-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-sequential-androgen-receptor-pathway-inhibitors-arpis-versus-novel-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-immunogenicity-and-efficacy-of-ad5f35-gucy2c-padre-vaccine-in-patients-with-gi-cancers-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precemtabart-tocentecan-precem-tct-m9140-an-anti-ceacam5-antibody-drug-conjugate-adc-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-socio-economic-status-indicators-barriers-for-enrollment-in-phase-1-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-across-epidermal-growth-factor-receptor-egfr-tyrosine-kinase-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-late-recurrence-patterns-and-immune-landscape-of-her2-positive-invasive-lobular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-egfr-alk-and-pd-l1-testing-performance-and-end-to-end-intervals-in-colombian-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-arpi-sequencing-in-mcrpc-a-propensity-matched-real-world-comparison-of-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraoperative-precision-margin-assessment-in-breast-conserving-surgery-using-handheld-fluorescence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-performance-status-as-a-predictive-tool-for-mortality-and-supportive-care-needs-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-urcc-ncorp-research-base-nationwide-phase-ii-randomized-controlled-trial-rct-investigating-the-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-homologous-recombination-deficiency-hrd-in-gastric-cancer-real-world-prevalence-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-enabled-clinical-trial-framework-for-end-to-end-site-recommendation-and-enrollment-projection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-vs-reactive-peg-tube-placement-in-early-stage-head-and-neck-hampn-cancer-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-circulating-tumor-dna-ctdna-burden-detected-mutations-and-clinical-outcomes-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/asc4first-wk-144-analysis-efficacy-and-safety-and-tolerability-with-asciminib-asc-vs-investigator 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-analysis-of-a-phase-ibii-combination-of-atezolizumab-cobimetinib-and-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-specific-circulating-tumor-dna-ctdna-positivity-and-minimal-residual-disease-mrd-decision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-folfiri-or-mfolfox6-as-second-line-therapy-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-pharmacodynamics-of-the-gcn2-activator-hc-7366-in-a-phase-1a-study-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spino-rt-a-multicenter-randomized-controlled-phase-iii-study-of-adjuvant-radiotherapy-versus-surve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-liposomal-curcumin-in-combination-with-standard-radiation-and-temozolomide-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspirin-use-and-outcomes-with-immune-checkpoint-inhibitors-in-metastatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-atypical-iegfri-mutations-in-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-racial-disparities-in-receipt-of-treatment-among-early-stage-erpr-her2-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/action-phase-1-study-of-sup225sup-acac-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-in-the-phase-3-trial-of-standard-chemotherapy-alone-or-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-combined-with-induction-chemotherapy-and-concurrent-chemoradiotherapy-in-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-evaluation-and-mitigation-strategies-for-approved-oncology-drug-and-non-cellular-biologic-produ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-safety-and-efficacy-of-puxitatug-samrotecan-puxi-sam-azd8205-in-patients-pts-with-endom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promise-or-predicament-real-world-analysis-of-molecular-targets-and-therapy-approaches-in-uro-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-adcs-and-emerging-conjugate-platforms-in-breast-cancer-a-clinicaltrialsgov-landsca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-profiling-to-identify-cancer-immune-meta-programs-in-penile-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sentinel-lymph-node-positivity-in-microinvasive-breast-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antiviral-prophylaxis-to-prevent-hepatitis-b-reactivation-in-patients-receiving-anti-cd20-based-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-initiation-of-first-line-immune-checkpoint-inhibitors-in-metastatic-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surrogate-end-points-for-overall-survival-a-meta-analysis-exploring-adequacy-of-progression-free-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-efficacy-of-cognitive-behavioral-therapy-on-anxiety-depression-and-distress-in-peopl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expressive-writing-for-body-image-distress-and-anxiety-in-adolescent-and-young-adult-cancer-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-chemoembolization-combined-with-donafenib-for-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pcsk9-inhibitors-and-association-with-lower-risk-of-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-multi-cancer-early-detection-test-mced-for-detecting-small-hepatocellular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deb-tace-combined-with-apatinib-and-camrelizumab-as-second-line-therapy-for-unresectable-intrahepati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ivonescimab-combined-with-liposomal-irinotecan-in-patients-with-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-the-rs72725854agtt-allele-and-prostate-cancer-in-males-of-african-ancestry-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-electronic-patient-reported-outcome-measure-eprom-triggered-collaborative-care-cc-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tbcrc-050-a-phase-1b2-trial-of-niraparib-and-trastuzumab-in-her2-positive-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-efficacy-between-2-and-3-cycles-of-neoadjuvant-immunotherapy-combined-with-chemotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-tumor-regression-after-neoadjuvant-immunochemotherapy-in-oral-squamous-cell-carcinoma-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-enablers-to-pediatric-palliative-care-integration-in-low-and-middle-income-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-nivolumab-ipilimumab-versus-chemotherapy-chemo-andor-immunotherapy-in-dmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osteoporosis-and-osteoporosis-related-fractures-among-older-male-cancer-patients-a-nationwide-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-as-a-predictor-of-immune-toxicity-and-efficacy-after-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/classification-tree-phenotypes-for-early-treatment-limiting-toxicity-after-androgen-receptor-pathway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-1167-m9466-a-parp1-inhibitor-combined-with-abiraterone-acetate-and-prednisone-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-unrelated-donor-allogeneic-hematopoietic-cell-transplantation-in-age-65-using-post-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-overall-survival-os-in-patients-pts-with-her2-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-based-individual-risk-prediction-for-late-mortality-a-report-from-the-childhood-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-validation-of-artificial-intelligence-ai-based-stratipath-breast-risk-stratification-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parent-willingness-to-enroll-children-with-acute-lymphoblastic-leukemia-in-escalation-and-de-escalat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peritumoral-stiffness-as-a-novel-noninvasive-biomarker-predicting-tace-response-in-intermediate-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-and-clinical-factors-with-overall-survival-in-immunotherapy-eligible-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-imtapi-loss-in-liquid-biopsies-from-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-baseline-ctdna-as-a-prognostic-biomarker-in-metastatic-urothelial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-accelerated-consolidative-gamma-knife-radiotherapy-following-brain-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-associations-between-ambient-pm25-and-pm10-and-lung-cancer-hospital-admissions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-as-a-shaper-of-immune-communication-in-the-triple-negative-breast-cancer-microenvironme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-bg-c9074-b7-h4-targeting-adc-in-advanced-solid-tumors-dose-escalation-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-thoracic-radiotherapy-in-metastatic-non-small-cell-lung-cancer-during-the-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantum-mechanics-based-multi-tensor-aiml-as-predictor-of-patients-overall-survival-gene-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-immune-checkpoint-inhibition-on-the-clinical-efficacy-of-belzutifan-in-advanced-rena 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-a-hybrid-tumor-informed-and-tumor-agnostic-ctdna-assay-for-optimal-ctdna-mrd-detection-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seer-based-projections-of-us-meningioma-and-glioblastoma-incidence-and-survival-through-2050 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-access-to-onc201-dordaviprone-trials-for-pediatric-diffuse-midline-glioma-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-structural-factors-associated-with-access-to-stereotactic-body-radiation-therapy-sbrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-chemotherapy-delivery-following-neuropathy-in-patients-with-stage-i-iiia-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-applicability-of-the-21-gene-assay-to-inform-chemotherapy-benefit-in-lymph-node-positive-hormone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-sys6043-a-novel-b7-h3-targeting-antibody-drug-conjugate-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-exchange-in-myeloma-associated-acute-kidney-injury-a-multicenter-propensity-matched-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-multicenter-validation-of-a-machine-learning-framework-for-predicting-severe-myelosu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-plus-pembrolizumab-p-versus-pembrolizumab-p-as-first-line-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-geography-the-intersecting-impact-of-rurality-race-and-depression-on-breast-cancer-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penpulimab-plus-oral-anlotinib-and-capecitabine-as-first-line-treatment-for-recurrent-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-n-of-1-combinations-based-on-molecular-profiles-in-advanced-malignancies-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-detection-of-homozygous-loss-homozygous-deletion-in-head-and-neck-cancer-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soho-01-updated-safety-and-efficacy-of-sevabertinib-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-electronic-frailty-index-used-to-identify-high-risk-older-adults-receiving-chimeric-antigen-rece 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-genomic-co-mutation-profiles-including-tp53-in-resected-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymoma-type-a-nos-a-national-cancer-database-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-baseline-fatigue-and-severe-cancer-treatment-toxicity-by-comorbid-conditions-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-hiv-status-as-survival-predictors-in-hhv8-positive-diffuse-large-b-cell-lymphoma-the-larges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-ml-based-six-gene-signature-for-risk-stratification-and-therapeutic-target-iden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-early-phase-cancer-clinical-trials-a-review-of-sponsor-supplied-information-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-remote-therapeutic-monitoring-with-patient-reported-outcomes-on-hospitalization-in-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-of-its-kind-multi-omic-assay-using-lipids-and-proteins-to-identify-early-stage-ovarian-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-ai-derived-lung-cancer-risk-and-social-determinants-of-health-to-improve-risk-stratifica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/budget-impact-analysis-of-heated-intraperitoneal-chemotherapy-at-interval-cytoreductive-surgery-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-apatinib-plus-camrelizumab-in-renal-cell-carcinoma-with-inferior-vena-cava-tumor-thrombu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fragmentia-ai-lymphoma-a-cfdna-language-model-for-lymphoma-detection-using-ultra-low-pass-wgs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-shocks-and-advance-care-planning-among-us-older-adults-evidence-from-hrs-2012-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-and-sequencing-of-cldn182-pd-l1-and-her2-testing-in-advanced-gastric-and-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-plus-kn046-and-chemotherapy-as-first-line-treatment-for-advanced-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-of-comprehensive-genomic-profiling-in-a-national-cohort-of-patients-with-resecte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-generative-ai-tools-by-cancer-patients-and-caregivers-a-cross-sectional-survey-of-awaren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-steroid-exposure-with-overall-survival-and-hypersensitivity-reaction-risk-in-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-plinabulin-plindocetaxel-doc-plus-pembrolizumab-pemb-in-metastatic-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-the-preoperative-cachexia-index-as-a-prognostic-predictor-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-high-risk-genomic-alterations-on-survival-outcomes-in-patients-with-stage-iii-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-chemotherapy-ct-on-dabrafenib-plus-trametinib-d-t-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-nodal-burden-in-tailor-rt-eligible-breast-cancer-an-ncdb-analysis-informing-regional-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-integrated-routine-biomarkers-for-breast-cancer-risk-stratification-a-scalable-str 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-intensive-care-unit-outcomes-for-lung-cancer-patients-a-15-year-analysis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-folfox-with-or-without-bevacizumab-in-small-bowel-and-ampullary-adenocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-cd38-treatment-patterns-in-multiple-myeloma-patients-with-medicaremedicaid-versus-private-insu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-malnutrition-on-in-hospital-outcomes-among-young-adults-hospitalized-with-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-outcomes-and-disparities-in-lung-cancer-related-hospitalizations-in-the-united-states-2012 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-antihypertensive-drug-classes-in-patients-with-gastrointestinal-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/placing-oncology-and-conflicts-of-interest-in-a-global-context-evidence-from-the-large-internationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-interactions-between-immune-cells-as-a-predictor-of-pcr-to-neoadjuvant-chemotherapy-nact-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-with-peripheral-blood-mononuclear-cells-deciphering-systemic-immunity-to-predict-parp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mtor-activation-and-racial-disparity-in-early-breast-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-sex-related-data-in-landmark-phase-iii-solid-tumor-trials-presented-at-asco-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-in-the-treatment-of-relapsed-refractory-multiple-myeloma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-value-based-breast-cancer-screening-in-a-safety-net-health-system-a-multimodal-approach-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-and-outcomes-of-a-real-world-cohort-of-carcinoma-of-unknown-primary-determ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-immune-profile-score-ips-signature-as-a-predictive-response-biomarker-to-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-second-line-sequencing-in-advanced-renal-cell-carcinoma-a-systematic-review-and-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/1l-olomorasib-plus-pembrolizumab-chemotherapy-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-identification-of-high-risk-lung-adenocarcinoma-histologic-subtypes-a-decision-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-frontline-gemcitabine-5-fluorouracilleucovorin-and-cisplatin-gemflp-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scaling-prior-authorization-for-philanthropic-funding-with-artificial-intelligence-ai-five-year-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-2-trial-of-cabozantinib-plus-nivolumab-cabonivo-in-patients-with-non-clea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-deulorlatinib-tgrx-326-in-patients-with-locally-advanced-or-metastatic-alk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-pancreatic-cancer-incidence-and-shifting-survival-trends-in-the-united-states-1999-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-second-primary-solid-tumors-in-patients-with-an-index-solid-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-selection-for-first-and-second-line-therapy-and-survival-outcomes-in-advanced-biliary-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-racial-and-ethnic-reporting-in-clinical-trials-cited-by-the-nccn-bladder-cancer-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-resq201a-of-nogapendekin-alfa-inbakicept-nai-plus-tislelizumab-and-docetaxel-vs-doc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-and-apatinib-combined-with-hepatic-arterial-infusion-chemotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-polatuzumab-rituximab-and-lenalidomide-in-frail-pts-with-diffuse-large-b-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-gy037-a-phase-iii-randomized-trial-of-induction-chemotherapy-and-pembrolizumab-followed-by-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-study-of-eik1001-in-combination-with-pembrolizumab-and-chemotherapy-in-participants-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-yttrium-90-radioembolization-on-epigenomic-immune-remodeling-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumor-efficacy-of-2-11-dimethyl-1h-benzoeindol-2-yl-567-trichloro-13-tropolone-on-variou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiii-randomized-double-blinded-placebo-controlled-study-of-suvemcitug-combined-with-triflu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inca033890-303-a-randomized-double-blind-phase-3-study-of-folfox-and-bevacizumab-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sonrotoclax-bgb-11417-zanubrutinib-sz-vs-venetoclax-acalabrutinib-av-in-treatment-naive-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chimeric-antigen-receptor-t-cell-therapy-in-diffuse-large-b-cell-lymphoma-dlbcl-a-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-outcomes-with-cannabis-use-disorder-in-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-profiles-and-cancer-stage-at-diagnosis-in-gastroesophageal-junction-adenocarcinoma-an-ordin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-biologic-therapy-for-immune-checkpoint-inhibitor-associated-colitis-a-propensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-trends-in-car-t-cell-therapy-and-bispecific-antibodies-among-medicare-beneficiaries-a-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-performance-of-child-pugh-and-meld-scores-in-critically-ill-patients-with-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-following-surgery-versus-non-surgical-management-for-gallbladder-cancer-patients-presenting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-immune-checkpoint-inhibitors-combined-with-chemotherapy-and-lenvatinib-for-biliary-tract-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-infiltrative-hepatocellular-carcinoma-and-efficacy-of-combination-treatment-for-conversio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphoma-histology-as-independent-predictor-of-icu-mortality-after-adjustment-for-illness-severity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-care-connected-access-and-remote-expertise-beyond-walls-pilot-phase-2-clinical-trial-to-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-response-to-sup177sup-lu-dotatat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/op-neu-101-a-phase-12-open-label-dose-finding-and-expansion-study-to-investigate-the-safety-and-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-inpatient-outcomes-in-hispanic-patients-with-primary-hccbiliary-tract-cancer-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-evaluating-microbiome-modulation-therapy-in-patients-undergoing-first-line-therapy-for-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-communication-about-cancer-management-and-cancer-care-delivery-for-older-adults-with-demen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratification-in-systemic-al-amyloidosis-with-cardiac-involvement-using-a-multiparametric-echo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-distinct-immune-microbiome-axis-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-extent-of-consensus-among-oncologists-in-treatment-selection-for-nsclc-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-solid-tumor-patients-characteristics-and-cure-expectations-with-their-portal-reporte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cost-of-inequity-estimating-the-impact-of-delayed-access-to-neoadjuvant-pertuzumab-in-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-cardiotoxicity-the-hidden-burden-of-functional-disability-in-cardio-oncology-survivorship 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-sepsis-associated-mortality-among-patients-with-gastrointestinal-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-prolymphocytic-leukemia-a-review-of-induction-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-1-trial-of-cisplatin-based-chemotherapy-with-or-without-sodium-thiosulfate-for-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognosis-of-anaplastic-and-poorly-differentiated-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-survival-after-induction-immunochemotherapy-followed-by-concurrent-chemoradiotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-variants-and-methylation-in-complex-genomic-regions-using-targeted-long-read-nanopore-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-propranolol-use-in-studies-of-beta-blockers-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/attenuation-of-long-term-survival-benefit-of-biological-therapy-in-metastatic-colorectal-cancer-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-melanoma-mortality-among-us-adults-aged-55-before-and-after-the-introduction-of-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-study-of-tyrosine-kinase-inhibitor-induced-hepatotoxicity-in-all-of-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-phenotypes-and-acute-care-escalation-in-hospitalized-patients-with-solid-tumors-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-rct-to-study-the-effect-of-chronotherapy-on-gefitinib-plasma-concentrations-and-adherence-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uniting-providers-across-institutions-to-support-osteosarcoma-care-insights-from-64-cases-reviewed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/faith-in-the-balance-examining-religious-and-spiritual-influences-on-cancer-treatment-decisions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-yield-of-percutaneous-versus-open-surgical-biopsy-for-tibial-bone-lesions-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-breath-volatile-organic-compound-analysis-for-detection-of-newly-diagnosed-treatment-naiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-patterns-and-management-after-frontline-platinum-in-advanced-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/morphological-features-of-melanoma-destruction-under-the-influence-of-egfr-inhibitors-gefitinib-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-performance-of-chatgpt-in-addressing-ethical-dilemmas-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-real-world-effectiveness-of-all-approved-brafmek-inhibitor-combinations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-outcomes-and-treatment-patterns-in-neuroendocrine-carcinoma-of-the-breast-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-plus-docetaxel-versus-docetaxel-monotherapy-in-advanced-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-iruplinalkib-in-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-cancer-stem-cell-markers-on-survival-outcomes-in-solid-tumors-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-concomitant-polychemotherapy-tec-versus-dose-dense-regimen-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-triple-negative-breast-cancer-tnbc-in-patients-with-residual-disease-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proof-of-concept-for-machine-learning-based-models-to-predict-response-to-anticancer-treatments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-immunotherapy-on-stage-iii-acral-malignant-melanoma-alm-in-a-peruvian-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-guided-multi-analyte-precision-oncology-based-platform-on-clinical-outcomes-in-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-anthracycline-containing-and-anthracycline-free-neoadjuvant-regimens-in-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-system-inequities-as-a-mediator-of-age-related-survival-differences-in-high-grade-serous-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-intratumoral-ifusobacterium-nucleatumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-treatment-and-survival-in-primary-tracheal-cancer-insights-from-a-global-real-world-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-diagnoses-and-inpatient-outcomes-in-principal-breast-cancer-hospitalizations-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-genomic-landscapes-at-single-cell-resolution-of-pulmonary-and-salivary-adenoid-cystic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-external-validation-of-a-recursive-attention-based-multimodal-deep-learning-model-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-modeling-with-electronic-health-records-through-natural-language-processing-and-machine-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-concurrent-chemoradiotherapy-withwithout-nimotuzumab-in-high-risk-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-cancer-patients-with-clonal-hematopoiesis-in-an-urban-county-hospital-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-representation-of-thyroid-cancers-in-contemporary-basket-clinical-trials-2018-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-followed-by-ivonescimab-and-capox-as-neoadjuvant-therapy-for-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-pathologic-complete-response-in-early-stage-triple-negative-breast-cancer-at-a-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-abstraction-of-colorectal-cancer-registry-data-using-ai-accuracy-and-implementation-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-ovarian-cancer-detection-with-a-multiomic-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-and-breast-specific-symptoms-among-long-term-survivors-of-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-loss-in-relation-to-mtorc1-activation-and-autophagy-suppression-shaping-an-immune-cold-phenotyp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-complications-and-perioperative-outcomes-following-total-mesorectal-excision-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-mortality-trends-in-colorectal-cancer-patients-with-psychiatric-and-respiratory-comorbiditi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-baseline-neurological-disorders-on-composite-gastrointestinal-toxicity-risk-in-cancers-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-landscape-of-mtap-deleted-thoracic-tumors-across-western-and-asian-cohorts-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-and-healthcare-resource-utilization-of-emergency-department-visit-etiology-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-amivantamab-monotherapy-in-advanced-egfr-mutant-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cervical-cancer-and-heart-failure-mortality-a-21-year-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/language-use-and-its-relationship-to-patient-experience-and-treatment-compliance-in-genitourinary-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-following-major-surgical-complications-in-gynecologic-oncology-a-national-inpatie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-mrd-and-post-remission-strategies-on-outcomes-following-dose-dense-mini-hyper-cvd-inot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1ab-study-of-ab248-a-cd8-selective-il-2-mutein-fusion-protein-alone-or-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-trial-investigating-the-safety-pharmacokinetics-pharmacodynamics-and-antitumor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-combined-with-immunotherapy-for-unresectable-intrahepatic-cho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-gata6-expression-as-a-biomarker-in-advanced-pancreatic-cancer-real-world-evidence-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-bl-m14d1-a-novel-dll3-directed-antibody-drug-conjugate-adc-in-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-the-insulin-like-growth-factor-system-in-non-small-cell-lung-cancer-tissue-and-hist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-chemoradiotherapy-plus-cytokine-induced-killer-cells-therapy-or-observation-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redtail-a-next-generation-systemic-platform-for-tumor-localized-expression-of-bites-and-immune-acti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/training-fellows-in-genomic-oncology-a-pilot-team-based-workshop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iia-study-of-tosposertib-a-dual-tgfvri-and-vegfr2-inhibitor-in-combination-with-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychological-burden-and-burnout-among-regional-healthcare-providers-communicating-hereditary-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cellular-consequences-of-a-germline-ismc5i-variant-enri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-management-of-advanced-stage-resectable-cutaneous-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-tiragolumab-plus-atezolizumab-across-solid-tumors-a-meta-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-retifanlimab-across-solid-tumors-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-level-clinical-response-dynamics-in-advanced-melanoma-with-anzutresgene-autoleucel-anzu-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transposable-elements-and-homotypic-niches-as-drivers-of-immune-dynamics-and-resistance-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-profiling-to-identify-chromosomal-instability-as-a-distinct-feature-of-lung-cancer-brai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-expression-of-ciita-the-master-mhc-ii-regulator-as-a-predictor-of-survival-benefit-from-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-jk06-a-5t4-targeted-antibody-drug-conjugate-adc-in-patients-with-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-evaluation-of-the-prame-targeted-immtac-brenetafusp-in-advanced-melanoma-mel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blinded-comparison-of-natural-killer-cell-detection-with-ai-driven-nanophotonic-imaging-versus-tradi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-genetic-polymorphism-underlying-immune-checkpoint-inhibitor-induced-endocrine-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-integrated-transcriptomic-clustering-for-prognostic-stratification-in-epithelioid-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-toripalimab-for-the-treatment-of-recurrent-ovarian-clear-cell-carcinoma-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-clinical-research-coordinator-led-care-delivery-model-crc-model-in-an-early-phase-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-ivermectin-medication-records-with-cancer-as-the-primary-diagnosis-following-public-attent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-a-novel-pd-l14-1bb-bispecific-antibody-qlf31907-in-previously-treated-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-ntx1088-a-first-in-class-anti-pvr-monoclonal-antibody-as-monotherapy-and-combined 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-early-onset-paradox-of-gastric-cancer-assessment-of-geographic-clustering-biology-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-harmonized-tumor-microenvironment-subtypes-for-patient-stratification-in-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-iii-study-evaluating-cts3497-an-mta-cooperative-prmt5-inhibitor-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-demographics-clinical-characteristics-and-hospitalization-burden-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-derived-mri-features-for-risk-stratification-in-post-surgical-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidation-pd-l1-inhibitor-after-definitive-chemoradiotherapy-for-unresectable-stage-iii-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-payer-based-disparities-in-inpatient-resource-utilization-and-mortality-among-patients-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-treatment-timing-with-recombinant-human-thrombopoietin-for-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-analysis-of-cancer-disparities-and-social-determinants-of-health-in-hereditary-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-tumor-naive-methylation-based-preoperative-ctdna-testing-with-pathologic-upstaging-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-evaluating-ssgj-707-pf-08634404-a-pd-1vegf-bispecific-antibody-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-burden-and-outcomes-across-gastrointestinal-cancer-subtypes-among-younger-adults-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathology-verified-comparison-of-fet-pet-and-contrast-enhanced-mri-for-tumor-visualization-in-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-phase-2-trial-of-ramucirumab-and-pembrolizumab-versus-pembrolizumab-as-fir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-function-eligibility-in-multiple-myeloma-car-t-and-bispecific-antibody-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidities-as-independent-predictors-of-mortality-in-lung-cancer-a-real-world-multivariate-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-respiratory-distress-syndrome-and-non-metastatic-solid-tumor-a-propensity-score-matched-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-reported-ethnicity-and-outcomes-of-newly-diagnosed-multiple-myeloma-ndmm-in-the-anti-cd38-mon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-avzo-021-a-selective-cyclin-dependent-kinase-2-inhibitor-cdk2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-machine-learning-integration-of-dna-and-rna-features-to-predict-immunotherapy-benefit-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-dedicated-care-coordination-on-access-to-multidimensional-support-services-in-young-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copernicus-a-pragmatic-phase-2b-study-of-first-line-1l-subcutaneous-sc-amivantamab-ami-laze 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scalable-knowledge-distillation-for-thyroid-cancer-diagnosis-resnet-based-ultrasound-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-mechanical-ventilation-in-metastatic-cancer-hospitalizations-a-national-inpatient-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-clonality-analysis-of-patients-with-metastatic-lung-limited-non-small-cell-lung-carcinoma-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-pd-1il-2-supa-biassup-bispecific-antibo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-pathology-driven-graph-neural-network-modeling-for-predicting-response-to-neoadjuvant-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-and-quality-of-life-qol-with-lenvatinib-everolimus-len-eve-versus-cabozanti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-mediated-targeting-of-secretory-protein-scube3-for-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/to-re-test-or-not-evaluating-candidacy-for-precision-therapy-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-patterns-and-patient-outcomes-for-metastatic-nsclc-crc-and-metastaticrecurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-mutational-signatures-in-advanced-cancer-patients-using-clinical-grade-specimens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-cabazitaxel-plus-carboplatin-versus-cabazitaxel-alone-in-metastatic-castratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-first-in-human-multicenter-monotherapy-and-combination-therapy-with-nivolumab-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/behavioral-predictors-of-pain-control-among-adult-cancer-survivors-examining-the-impact-of-smoking 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-plus-chemotherapy-and-radiotherapy-for-treatment-naive-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-cabomain-a-prospective-single-arm-phase-2-clinical-trial-of-cabozantinib-as-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-algorithm-for-optimizing-treatment-selection-for-patients-with-up-to-three-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incorporating-ca19-9-testing-in-a-prospective-study-of-pancreatic-cancer-surveillance-pcs-among-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-the-keynote-811-standard-of-care-using-ai-reconstructed-external-control-arms-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-azer-cel-an-allogeneic-cd19-car-t-for-the-treatment-of-patients-with-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-selective-serotonin-reuptake-inhibitor-use-and-outcomes-in-metastatic-melanoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-whole-food-plant-based-diet-wfpbd-on-weight-and-metabo-inflammation-in-men-with-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-genetic-analysis-of-orelabrutinib-combined-with-rituximab-as-first-line-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prior-sars-cov-2-infection-with-advanced-cancer-presentation-in-newly-diagnosed-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-medications-on-immune-checkpoint-inhibitor-outcomes-in-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-monthly-gonadotropin-releasing-hormone-agonist-for-ovarian-function-suppression-in-premenopaus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bevacizumab-on-the-efficacy-of-antibody-drug-conjugates-as-later-line-treatment-of-basal-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-actionable-machine-learning-driven-clinicogenomic-model-as-a-predictor-of-brain-metastasis-risk-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/car-t-cell-detection-and-clonality-assessment-in-immune-effector-cell-associated-enterocolitis-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-tgf-v-inhibition-galunisertib-enhance-response-to-enzalutamide-in-metastatic-castration-resist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-2-study-of-hydroxychloroquine-hcq-and-chlorphenesin-carbamate-cpc-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-combined-with-donafenib-and-gemox-as-first-line-treatment-for-advanced-biliary-tract-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-disparities-in-current-clinical-trials-in-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lusato-1-phase-i-study-of-sup177sup-lu-sso110-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cabozantinib-cabo-in-advanced-neuroendocrine-tumors-net-according-to-horm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-novel-blood-based-lung-cancer-screening-test-in-elevated-risk-subjects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-advanced-age-on-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-in-treatment-naive-patients-with-cllsll-pooled-results-from-bruin-cll-313-and-bruin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-fluorouracil-fu-leucovorin-lv-and-nanoliposomal-irinoteca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hearingvestibular-dysfunction-and-longitudinal-changes-in-psychosocial-well-being-among-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-of-participants-pts-with-her2-ihc0-in-the-ascent-07-study-of-sacituzumab-govitec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-combined-with-paclitaxel-and-cisplatin-as-first-line-treatment-for-metastatic-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-and-diagnostic-utility-of-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-determinants-of-radiotherapy-treatment-default-in-a-rural-cancer-centre-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurosensory-deficits-and-functional-outcomes-in-childhood-cancer-survivors-a-report-from-the-child 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-low-coverage-whole-genome-sequencing-based-urinary-tumor-fraction-and-chromosomal-insta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-the-role-of-tumor-size-in-bladder-preservation-comparing-survival-outcomes-of-radical-cy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-high-postoperative-physical-activity-with-ctdna-mrd-positivity-and-recurrence-free-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-tumor-infiltrating-iymphocytes-tils-in-the-biomarker-landscape-of-gastroesophageal-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expansion-of-a-highly-activated-hla-drcd38-car-t-cell-population-after-mezigdomide-exposure-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-hidacmitoxantronevenetoclax-hmv-in-patients-with-relapsedrefractory-rr-acute-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-mpmri-guided-salvage-radiotherapy-with-lesion-directed-dose-escalation-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-markers-of-resistance-to-first-line-1l-therapy-with-a-cdk46-inhibitor-cdki-and-endocrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-burden-of-childhood-cancers-in-the-south-asian-association-for-regional-cooperation-saarc-regi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-recurrence-risk-factors-of-liver-transplantation-for-permanently-unresectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-genomics-imaging-and-clinical-data-for-late-onset-cardiomyopathy-prediction-in-pediatr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-residual-disease-post-neoadjuvant-sacituzumab-govitecan-sg-pembroli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ctdna-tumor-fraction-and-confidence-in-driver-negative-liquid-biopsy-findings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-related-30-and-90-day-readmissions-among-patients-with-pancreatic-cancer-a-nationwide-readm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-related-to-anal-carcinoma-in-the-united-states-1999-2023-a-population-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-creatine-riboside-for-risk-stratification-of-clinically-significant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-copd-related-mortality-among-adults-with-lung-cancer-in-the-united-states-1999-2025-a-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-mortality-trends-of-malignant-melanoma-associated-with-cerebrovascular-diseases-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-demographic-landscape-of-advanced-cutaneous-melanoma-a-10-year-experience-of-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circrna-signatures-to-identify-candidate-biomarkers-of-treatment-resistance-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-psychological-distress-during-chemotherapy-assessment-of-anxiety-and-depression-in-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-23-clinical-trial-investigating-rp2-plus-nivolumab-vs-ipilimumab-plus-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-composition-on-prognosis-treatment-toxicity-and-surgical-complications-in-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stars-nct-07265661-surgical-timing-after-preoperative-hypofractionated-radiotherapy-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-supervised-physical-activity-into-breast-cancer-survivorship-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-for-early-detection-of-suspicious-lung-nodules-in-latin-america-lucas-latam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epcore-nhl-6-phase-2-study-of-subcutaneous-sc-epcoritamab-as-outpatient-treatment-for-2l-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerated-failure-time-as-an-alternative-to-cox-proportional-hazards-for-parathyroid-carcinoma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-st316-a-first-in-class-ss-catenin-antagonist-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-to-neoadjuvant-immunochemotherapy-in-locally-advanced-head-and-neck-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-tumor-informed-ctdna-monitoring-for-recurrence-in-high-risk-locally-advanced-gastrointe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-mortality-among-patients-with-neoplasms-national-trends-and-deep-learning-forec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-use-with-overall-survival-in-patients-with-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-patterns-of-malignant-melanoma-in-junctional-nevus-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/morphologic-and-genomic-changes-in-clinical-relapse-of-young-onset-tongue-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-esophageal-cancer-burden-across-africa-1990-2023-a-global-burden-of-disease-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-combined-with-immunonutrition-therapy-for-gastric-cancer-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-at-diagnosis-and-survival-outcomes-in-esophageal-carcinoma-a-multicenter-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-colorectal-cancer-mutations-and-their-associated-risk-of-oxaliplatin-induc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-adverse-childhood-experiences-aces-and-common-cancers-in-the-all-of-us-databas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fear-of-cancer-recurrence-in-oncology-follow-up-prevalence-and-the-role-of-patient-oncologist-commu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-melatonin-on-the-fatigue-sleep-and-depression-symptom-cluster-in-breast-cancer-according 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-mucin-expression-in-the-early-diagnosis-of-esophagogastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-an-established-oncology-program-for-adolescents-and-young-adults-the-ro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-sintilimab-and-capeox-as-first-line-treatment-for-advanced-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-tumor-mutation-status-pretreatment-weight-change-and-overall-survival-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-methylene-blue-vital-staining-for-early-detection-of-oral-epithelial-dyspl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-genome-wide-modifiers-of-response-to-next-generation-fgfr-inhibitors-in-solid-tumors-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supportive-care-prescribing-a-real-world-comparison-of-community-vs-academic-oncology-practices 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-laparoscopic-versus-open-gastrectomy-for-far-advanced-gastric-cancer-after-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-circulating-tumor-dna-as-a-disease-monitoring-biomarker-in-soft-tissue-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-gaps-in-relapsedrefractory-follicular-lymphoma-care-perceived-barriers-to-treatment-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratified-cancer-screening-in-idiopathic-inflammatory-myopathies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-chemotherapy-and-immunotherapy-encounters-in-the-united-states-recent-trends-acute-compl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-expandable-metallic-versus-plastic-biliary-stents-in-malignant-biliary-obstruction-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-study-of-mirdametinib-in-combination-with-palbociclib-in-patients-with-advanced-dediff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-butyrate-and-chenodeoxycholic-acid-cdca-for-anti-inflammatory-and-hepatoprotective-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/somatic-and-actionable-genomic-alterations-in-early-onset-colorectal-cancer-versus-late-onset-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparison-of-data-processing-methods-to-support-patient-matching-to-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-asxl1-somatic-mutation-on-patients-with-chronic-myeloid-leukemia-a-systemic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-exposure-to-erythropoiesis-stimulating-agents-esa-on-thromboembolic-events-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-equity-in-breast-cancer-biomarker-testing-an-updated-study-on-hospital-settings-and-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-therapy-with-pd-1pd-l1-inhibitors-plus-gemcitabine-based-chemotherapy-for-initially-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-the-oncolytic-virus-svv-001-with-nivolumab-and-ipilimumab-in-patients-with-high-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-macrophage-migration-inhibitory-factor-a-phase-2-and-pharmacodynamic-study-of-sitagliptin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enrollment-outcomes-after-screening-in-phase-1-oncology-clinical-trials-real-world-evidence-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-klotho-protein-with-the-risk-of-late-complications-in-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cns-exile-an-ai-driven-audit-of-active-brain-metastasis-exclusions-in-modern-nsclc-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-hepatic-arterial-infusion-chemotherapy-plus-pd-1pd-l1-antibodies-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chronic-kidney-disease-on-adverse-event-topography-and-economic-burden-in-car-t-cell-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-design-of-invoke-a-phase-1-study-of-okn4395-a-first-in-class-ep2ep4dp1-triple-prostanoid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-donafenib-based-therapy-for-patients-with-hepatocellular-carcinoma-at-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-and-stroke-mortality-trends-in-middle-aged-and-older-us-adults-1999-2023-a-cdc-wonder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-mir-181-5p-mir-214-3p-and-mir-223-3p-expression-in-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-following-first-line-treatment-of-mss-metastatic-colorectal-cancer-a-pooled-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardizing-communication-during-icu-transfers-of-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-precision-treatment-with-artificial-intelligence-assisted-subtyping-on-first-line-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-local-mucosal-patterns-vision-transformer-based-modeling-for-diagnosis-of-gastric-tumors-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-to-predict-anthracycline-induced-cardiotoxicity-in-adult-hematologic-malignancies-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-robot-assisted-interval-debulking-surgery-in-older-women-with-advanced-ovarian-cancer-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-triple-negative-breast-cancer-patients-with-brain-metastases-a-multicenter-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-antibody-drug-conjugates-in-advanced-colorectal-cancer-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspiration-pneumonitis-and-inpatient-outcomes-in-adult-cancer-hospitalizations-a-2018-2022-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-stratified-outcomes-hormone-receptor-expression-and-treatment-utilization-in-neuroendocrine-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-targeted-therapy-response-in-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reversible-epigenetic-control-of-cd146-phenotypic-states-in-mda-mb-231-breast-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-use-of-antibody-drug-conjugates-in-advanced-breast-cancer-a-real-world-study-based-on-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-spatial-omics-to-identify-determinants-of-response-to-neoadjuvant-chemo-immunotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-of-patients-with-metastatic-uveal-melanoma-and-assessment-of-long-term-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-for-cervical-cancer-related-mortality-rates-from-1999-2020-a-national-inpatient-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ea3231-a-randomized-phase-iii-study-of-braf-targeted-therapy-vs-cabozantinib-in-rai-refractory-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspria-a-single-arm-phase-2-trial-of-atezolizumab-with-sacituzumab-govitecan-to-prevent-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-study-of-capmatinib-plus-osimertinib-with-or-without-ramucirumab-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-momelotinib-during-and-following-hematopoietic-stem-cell-transplantation-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-year-landmark-survival-analysis-of-low-dose-nivolumab-added-to-metronomic-chemotherapy-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-effects-of-darolutamide-vs-enzalutamide-results-of-aracog-aft-47-a-randomized-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-glp-1-receptor-agonists-on-cancer-recurrence-and-survival-of-patients-with-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sglt2-inhibitors-and-glp-1-receptor-agonists-or-dpp-4-inhibitors-with-incident-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-glp-1-receptor-agonist-use-with-survival-and-immune-related-adverse-events-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sotorasib-vs-adagrasib-in-the-2l-setting-outcomes-in-a-large-multi-institutional-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-results-with-prame-directed-t-cell-receptor-tcr-t-cell-therapies-in-synovial-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-destiny-breast09-analysis-of-treatment-duration-and-clinical-outcomes-by-best-response-to-trastuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dareon-8-updated-efficacy-and-safety-from-a-phase-i-dose-escalationexpansion-trial-of-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-doxorubicin-and-paclitaxel-in-advanced-kaposi-sarcoma-a-trinetx-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-anlotinib-combined-with-etoposide-plus-ifosfamide-in-the-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-correlates-of-deep-psa-response-in-patients-with-metastatic-hormone-sensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-whole-genome-sequencing-based-molecular-residual-disease-detection-in-resectable-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-dual-epitope-nanobody-anti-cd5-car-t-for-relapsedrefractory-t-allptcl-phase-i-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrepancy-between-plasma-cell-free-dna-and-tissue-based-analysis-for-detection-of-gene-amplificati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reirradiation-with-nbtxr3sbrt-in-combination-with-nivolumab-or-pembrolizumab-for-the-treatment-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-tumor-suppressor-and-dna-damage-repair-gene-mutations-in-oral-cavity-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-anticancer-therapy-in-patients-with-de-novo-metastatic-pancreatic-adenocarcinoma-a-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-robotic-surgery-better-preserve-sensory-function-the-significance-and-strategy-of-nerve-preser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationships-between-clinical-stage-pathological-stage-and-disease-free-dfs-survival-in-renal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-correlates-of-leptomeningeal-disease-after-brain-metastasis-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-advanced-or-metastatic-ireti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-genomic-hla-class-i-allelic-imbalance-on-enduring-immunotherapy-response-in-advanced-non-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-science-insights-from-a-community-embedded-cervical-cancer-screening-program-integrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-multi-scale-histopathologic-classification-of-epithelial-ovarian-cancer-to-support-precisi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-continuous-intra-arterial-cisplatin-and-recombinant-human-endostatin-combined 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-ct-benefit-in-invasive-lobular-carcinoma-ilc-by-oncotype-dx-recurrence-sco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-dan-222-plus-niraparib-in-high-risk-her2-negative-breast-cancer-results-from-the-i-spy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effectiveness-of-a-multidisciplinary-pain-program-in-improving-adherence-to-the-use-of-aromatase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-gabapentinoids-for-oncologic-pruritus-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-capacity-assessment-of-pediatric-oncology-research-biorepositories-across-a-regional-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-to-add-prognostic-stratification-beyond-ca-125-in-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ibrcai-pathogenic-variants-and-novel-targeted 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-results-and-adverse-event-ae-management-recommendations-in-patients-with-erher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autologous-natural-killer-cell-infusion-as-consolidation-therapy-after-first-line-chemoradiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-trial-of-tersolisib-ly4064809stx-478-a-pan-mutant-selective-pi3ka-inhibitor-pi3kai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-utidelone-capsule-the-first-solid-oral-microtubule-stabilizer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-receptor-ar-gene-dynamics-in-ctdna-post-abirateroneenzalutamide-longitudinal-study-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-the-70-gene-assay-and-homologous-recombination-deficiency-in-patients-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-or-further-line-kc1036-in-patients-with-thymoma-and-thymic-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bal0891-as-monotherapy-and-in-combination-with-paclitaxel-results-from-a-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-acquired-sepsis-as-a-driver-of-failure-to-rescue-in-aml-and-mds-a-national-inpatient-sampl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-mucositis-as-a-predictor-of-differential-long-term-adverse-events-and-mortality-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-as-a-predictor-of-response-to-platinum-based-chemotherapy-and-parp-inhibitors-in-a-chinese-ovari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-linked-complementary-care-ai-supporting-standard-oncology-real-world-outcomes-in-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-validation-of-ialki-fusions-by-rna-step 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-in-armenia-current-situation-and-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/environmental-co-benefits-of-wisdom-risk-based-breast-cancer-screening-a-multi-institutional-pathwa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-cancer-signature-eocs-pan-cancer-molecular-alterations-with-prognostic-significance-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-preferences-in-large-language-models-for-breast-cancer-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-persistent-disparities-among-us-adults-with-lung-cancer-and-hypertensive-dise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-darolutamide-therapy-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-darolutamide-based-triplet-therapy-in-chinese-patients-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-and-neoadjuvant-evaluation-of-a-structural-variant-based-mrd-assay-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wearable-derived-physical-activity-monitoring-with-ai-based-detection-of-treatment-related-adverse-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-post-operative-circulating-tumor-dna-ctdna-in-real-world-treatment-and-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sars-cov-2-infection-vaccination-and-mgus-progression-with-covid-19-outcomes-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-enfortumab-vedotin-ev-rechallenge-after-disease-progression-in-metastatic-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-domain-disruption-to-define-the-molecular-and-clinical-spectrum-of-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-spop-mutation-with-survival-outcomes-following-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-to-stratify-metastatic-breast-cancer-progression-risk-using-multi-analyte-cell-subtypi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-peripheral-blood-activated-to-total-cd8-central-memory-t-cell-ratio-to-identify-melanoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endothelin-1-levels-in-lung-tissue-of-patients-with-non-small-cell-lung-cancer-with-previous-covid-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-associations-of-the-g8-geriatric-screening-tool-in-the-eortc-brain-tumor-group-trials-160 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-landscape-and-trends-of-antibody-drug-conjugates-in-oncology-a-machine-learning-driven-decad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-on-safety-and-efficacy-of-hypofractionated-versus-conventional-fractionated-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-translation-of-pepticrad-1-interim-clinical-evaluation-of-a-modular-oncolytic-adenovirus-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-invasive-methylation-based-ngs-assay-for-sensitive-detection-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-representation-in-first-and-senior-authorship-of-phase-iii-solid-tumor-trials-presented-at-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-study-of-ybx1-as-a-biomarker-and-therapeutic-target-in-bone-metastasis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-discovery-and-curation-of-public-spatial-transcriptomic-datasets-across-multiple-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-the-mechanisms-of-alpha-linolenic-acid-in-influencing-the-efficacy-of-immunotherapy-for-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-immune-and-gut-microbial-metabolic-profiles-associated-with-hepatic-immune-related-adverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-diagnostic-utility-of-cerebrospinal-fluid-ctdna-in-central-nervous-system-lymphoma-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-rates-in-pediatric-and-adolescent-melanoma-in-the-united-states-2001-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-g-csf-after-venetoclax-based-induction-for-acute-myeloid-leukemia-multicenter-associations-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-controlled-trial-of-fapi-petct-guided-radiotherapy-combined-with-second-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multivariable-analyses-mvas-of-overall-survival-os-in-the-phase-3-sunmo-starglo-and-polargo-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-to-identify-novel-clinically-relevant-findings-missed-by-standard-of-care-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-longitudinal-circulating-tumor-dna-ctdna-and-carcinoembryonic-antigen-cea-for-post 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-local-and-systemic-efficacy-in-refractory-solid-tumors-via-integrated-intra-tumoral-injecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-t-cell-subsets-as-drivers-of-response-to-different-neoadjuvant-treatments-in-esophageal-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-pancreatic-cancer-incidence-mortality-and-disability-adjusted-life-years-in-pak 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-survivorship-care-plans-patients-needs-benefits-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-liquid-ikrasi-mutation-screening-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-discordances-between-histomorphology-and-molecular-biomarkers-in-precision-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-long-mononucleotide-repeat-microsatellite-instability-testing-for-detection-and-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neighborhood-socioeconomic-deprivation-and-diet-quality-on-immune-checkpoint-blockade-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zip-code-level-distress-as-a-predictor-for-advanced-stage-and-mortality-in-female-breast-cancer-acro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-re-profiling-for-identification-of-missed-drivers-and-a-high-risk-fusion-subgroup-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-methylation-profile-based-fusion-epigenotyping-to-enhance-ialk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-tissue-and-plasma-ngs-in-early-stage-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-disparities-among-adults-with-advanced-cancer-hospitalized-for-sepsi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-salvage-surgery-for-recurrent-and-residual-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-crs-and-icans-following-tarlatamab-and-its-association-with-survival-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-existing-mental-health-diagnosis-and-colorectal-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-colorectal-cancer-in-renal-transplant-recipients-compared-with-the-general-population-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intersectional-analysis-of-raceethnicity-geography-and-socioeconomic-status-on-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-expression-of-m6a-modified-acly-immunotherapy-resistance-and-poor-survival-in-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-trust-in-health-information-sources-among-persons-with-a-cancer-diagnosis-an-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adenoid-basal-carcinoma-an-ncdb-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-outcomes-of-first-line-maintenance-therapy-in-ovarian-cancer-stratified-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-thyroid-cancer-in-hanoi-incidence-trends-and-projections-to-2045-from-the-hanoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-ameloblastoma-real-world-outcomes-of-a-rare-odontogenic-malignancy-using-the-seer-databas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reactive-versus-prophylactic-percutaneous-endoscopic-gastrostomy-in-patients-with-head-and-neck-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-association-between-federal-ai-investment-and-clinical-validation-in-oncology-a-multi-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uveal-melanoma-a-retrospective-cohort-study-of-long-term-outcomes-and-impact-of-surveillance-imagin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-melanoma-immune-profile-mip-to-predict-rfs-in-stage-ii-iii-melanoma-on-adjuvant-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-oral-feeding-after-esophagectomy-for-esophageal-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-national-mortality-analysis-in-hospitalized-patients-with-cancer-diagnoses-using-machine-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-radiotherapy-access-and-workflow-efficiency-in-a-resource-limited-tertiary-center-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/education-income-treatment-and-survival-a-retrospective-cohort-study-of-patients-with-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-male-breast-cancer-what-do-we-know-about-treatment-efficacy-and-survival-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-venetoclax-dosing-on-outcomes-in-aml-a-single-center-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/female-cancer-patterns-and-treatment-disparities-in-southeastern-para-brazilian-amazon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatiotemporal-evolution-of-immune-evasion-divergent-resistance-mechanisms-in-primary-refractory-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-skin-cancer-with-bruton-tyrosine-kinase-inhibitors-a-faers-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-genomic-dna-stability-and-white-blood-cell-integrity-in-tflb-and-streck-blood-collecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-clinical-impact-of-totally-implantable-venous-access-ports-during-trabectedin-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-ketogenic-diet-and-psychological-factors-on-tumor-shrinkage-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/publication-pathways-and-impact-metrics-of-african-cancer-research-presented-at-major-international 2026-08-24 monthly 0.7 https://rjrindex.com/articles/education-and-decision-making-autonomy-as-drivers-of-hpv-screening-outcomes-in-nepal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-commercial-cd19-car-t-inaticabtagene-autoleucel-in-relapsedrefractory-extr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-cdk46-inhibitors-in-early-and-metastatic-hrher2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-liposomal-irinotecan-plus-fruquintinib-as-third-or-later-line-therapy-for-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-mortality-and-contemporary-survival-in-intravascular-large-b-cell-lymphoma-a-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-lenvatinib-versus-sorafenib-in-advanced-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-treatment-delay-on-outcomes-with-adjuvant-chemotherapy-vs-chemoradiotherapy-in-r1-resected 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-houses-index-a-novel-patient-level-measure-of-socioeconomic-status-linking-real-world-housing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-open-label-clinical-trial-to-treat-stage-iv-cancer-patients-harboring-multiple-patient-spec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/asp2998-a-trophoblast-cell-surface-antigen-2-trop2-targeted-immunostimulatory-antibody-drug-conju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-fertility-preservation-counseling-in-young-cancer-patients-a-retrospective-chart-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-multiple-primary-malignancies-in-mantle-cell-lymphoma-insights-from-a-seer-based-study-200 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-ivonescimab-in-combination-with-chemotherapy-as-first-and-second-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-liver-cancer-mortality-due-to-hepatitis-b-in-sub-saharan-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-ros1-tyrosine-kinase-inhibitors-for-advanced-ros1-positive-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-artificial-intelligence-ai-scribes-ais-by-the-hematology-and-oncology-hemonc-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-for-monitoring-disease-status-in-hpv-negative-head-and-neck-cancer-in-an-underserved-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-electronic-best-practice-advisory-on-fertility-preservation-referral-and-consultation-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-great-mismatch-assessing-cancer-clinical-trial-accrual-rates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/right-sided-circulatory-failure-without-pulmonary-embolism-in-hospitalized-cancer-patients-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-risk-in-msh2-and-msh6-lynch-syndrome-female-patients-a-single-institution-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-govitecan-in-combination-with-capecitabine-for-the-treatment-of-advanced-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aquarius-a-longitudinal-multi-center-molecular-biomarker-discovery-registry-for-patients-with-hemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-forecasting-of-car-t-related-toxicities-using-meta-analytic-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-immune-related-adverse-events-in-the-neoadjuvant-and-adjuvant-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-with-or-without-locoregional-therapy-for-biliary-tract-cancer-a-propensity-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-blood-based-translational-pcr-screen-for-monoclonal-b-cell-lymphocytosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-risk-factors-and-outcomes-of-tumor-lysis-syndrome-in-hospitalized-patients-with-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-almonertinib-followed-by-chemo-immunotherapy-in-ii-iiib-egfr-mutant-nsclc-a-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-agonists-with-breast-cancer-incidence-in-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fuzuloparib-combined-with-abiraterone-acetate-and-prednisone-aa-p-as-first-line-1l-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camizestrant-plus-ribociclib-in-hormone-receptor-positiveher2-negative-advanced-breast-cancer-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electra-an-open-label-multicenter-phase-1b2-study-of-elacestrant-in-combination-with-abemaciclib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-add-on-ruxolitinib-for-patients-with-severe-checkpoint-inhibitor-pneumoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-encapsulated-actinomycin-d-for-targeted-cancer-treatments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-giredestrant-gire-in-patients-pts-with-estrogen-receptor-positive-her2-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-phase-1-study-results-of-nt-175-engineered-t-cell-therapy-in-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-racial-socioeconomic-and-tumor-characteristics-on-potential-years-of-life-lost-pyll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/car-mix-cell-therapies-to-treat-solid-tumors-by-providing-synergistic-interaction-between-engineered 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-mitochondrial-apoptosis-profile-in-meningiomas-and-gliomas-comparing-the-effects-of-patient-sex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/has-early-detection-improved-trends-in-localized-pdac-diagnoses-in-the-us-2004-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-first-in-human-study-of-the-mc1r-targeting-radiopharmaceutical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-cfdna-methylation-based-multi-cancer-early-detection-mced-assay-to-enable-subtypin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-management-strategies-and-outcomes-of-brain-metastases-in-patients-with-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/older-adults-with-extensive-stage-small-cell-lung-cancer-treated-with-first-line-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-targeting-replication-stress-in-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-intermittent-oral-prtx007 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zidesamtinib-efficacy-and-safety-in-patients-with-advanced-iros1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-automated-prostate-cancer-risk-assessment-an-ensemble-llm-framework-for-clinical-t-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-renal-cell-carcinoma-treated-with-pembrolizumab-lenvatinib-versus-nivolumab-cabozantinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-xnw27011-a-claudin-182-targeted-cldn182-adc-in-advanced-pancreatic-duct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zirconium-engineered-nanoplatform-to-enhance-radiotherapy-through-nod-like-receptor-mediated-pyropto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imneskibart-low-dose-subcutaneous-il-2-nivolumab-in-patients-with-cpi-refractory-cutaneous-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-hypofractionated-versus-conventional-radiotherapy-following-mastectomy-for-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pro-results-from-the-beamion-lung-1-trial-in-treatment-naive-patients-with-ihe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-coronary-heart-disease-and-hepatocellular-carcinoma-mortality-among-us-adults-a-25-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-analysis-of-cancer-care-for-refugees-in-moldova-during-the-war-in-ukraine-2022-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-nivolumab-ipilimumab-in-metastatic-renal-cell-carcinoma-by-nephrectomy-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-timing-of-circulating-tumor-dna-ctdna-dynamics-to-prognosticate-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-tumor-informed-ctdna-mrd-detection-to-identify-metastatic-relapse-and-as-predictor-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-characterization-of-the-tumor-microenvironment-landscape-in-her2-overexpressing-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eik1003-a-parp1-selective-inhibitor-in-combination-with-paclitaxel-ptx-initial-combination-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-met-inhibitors-versus-immunotherapy-chemotherapy-in-1l-for-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immunotherapy-infusion-timing-with-outcomes-in-early-stage-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-genomic-discordance-and-chemotherapy-ct-outcomes-in-early-stage-hrher2-invasive-lobula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-pre-cystectomy-ctdna-levels-for-identification-of-ctdna-positive-patients-with-surgical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-rtk-ras-pathway-alterations-by-treatment-type-the-md-anderson-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrupting-heg1cx43-interaction-to-promote-cuproptosis-via-inhibiting-gap-junction-to-overcome-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-implicating-human-papillomavirus-in-bladder-carcinogenesis-a-case-control-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kras-mutational-landscape-and-immune-microenvironment-features-in-pancreatic-cancer-implications-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lutetium-177-psma-617-sup177sup-lu-psma-617-in-neuro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-based-mutation-profiling-in-solid-tumors-a-study-from-a-north-indian-ter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-ceacam7-as-a-novel-diagnostic-biomarker-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-ctc-enumeration-and-ar-v7-detection-using-a-microporous-chip-filtration-system-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-photoimmunotherapy-for-recurrent-nasopharyngeal-carcinoma-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-furmonertinib-in-the-treatment-of-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-multiple-myeloma-patients-achieving-mrd-negativity-at-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-therapeutic-intervention-versus-observation-in-high-risk-smoldering-multiple-myeloma-a-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-the-pulmonary-immune-microenvironment-from-premalignant-lesions-to-invasive-lung-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rab11-family-interacting-proteins-as-regulators-of-t-cell-recognition-and-infiltration-in-triple-neg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-adoptive-cellular-therapy-with-lifileucel-in-patients-with-advanced-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-type-stratified-causal-machine-learning-to-identify-heterogeneous-benefit-of-pd-l1ctla-4-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-predictors-of-early-mortality-in-patients-with-pd-l1-high-advanced-nsclc-treated-with-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-pembrolizumab-combined-with-chemotherapy-in-platinum-sensitive-recurrent-low-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-we-omit-surgical-axillary-staging-in-early-stage-invasive-lobular-carcinoma-results-from-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-a-novel-oral-serd-tfx06-in-prior-fulvestrant-treated-erher2-advanced-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cisplatingemcitabine-or-carboplatingemcitabine-on-efficacy-toxicity-and-quality-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dentist-led-systematic-oral-education-programs-in-the-prevention-of-radiation-induced-oral-toxicitie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immunotherapy-based-regimens-in-russian-patients-with-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-squamous-and-non-squamous-penile-cancers-insights-from-seer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-serum-tumor-markers-in-phase-i-immunotherapy-trials-a-single-institution-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-resistance-to-immune-checkpoint-inhibition-in-advanced-cutaneous-squamou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-preservation-in-patients-with-urothelial-muscle-invasive-bladder-cancer-who-refused-radical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-specific-supportive-care-utilization-after-first-line-pd-1-inhibitor-therapy-real-world-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-therapeutically-actionable-hrr-gene-variants-in-moroccan-breast-and-ovarian-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-apatinib-combination-with-first-line-chemotherapy-rechallenge-in-advanced-osteosarcoma-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-itp53i-y220c-mutated-clinically-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hspa6-on-lenvatinib-resistance-in-hcc-via-phase-separation-mediated-txnrd1-stabilization-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-survival-after-chemo-immunotherapy-in-veterans-with-extensive-stage-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-use-hcru-intensity-prior-to-cancer-diagnosis-and-real-world-outcomes-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-bevacizumab-bev-as-first-line-1l-maintenance-therapy-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-hematologic-malignancies-clonal-hematopoiesis-of-indeterminate-potential-and-the-risk-of-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup68sup-ga-ga-nym096-petct-in-patients-with-primar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organotropic-and-genomic-characterization-of-pancreatic-neuroendocrine-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-serplulimab-for-locally-advanced-or-metastatic-squamous-non-small-cell-lung-cancer-updat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-double-arm-open-label-controlled-study-of-asp-1929-photoimmunotherapy-pit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-nutritional-factors-on-disease-control-and-survival-in-patients-with-recurrentme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ablation-plus-immunotherapy-in-advanced-nsclc-patients-who-develop-oligo-residual-disease-after-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-specific-trends-in-liver-cancer-mortality-in-the-united-states-1999-2023-a-joinpoint-regressio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-exploratory-study-on-the-efficacy-and-safety-of-romiplostim-n01-for-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-fndc1-and-gv2-in-suppression-of-the-v-catenin-destruction-complex-and-promotion-of-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-clinicopathological-features-and-prognosis-of-patients-with-small-cell-carcinoma-of-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-burden-of-cholangiocarcinoma-in-the-united-states-a-20-year-analysis-of-temporal-trends-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-barriers-to-treatment-access-and-home-delivery-in-rare-cancers-across-five-european 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-sinus-involvement-in-meningiomas-and-its-association-with-intracranial-hypertension-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-decade-national-trends-and-forecasting-of-brain-tumor-mortality-among-older-adults-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tgf-v-signaling-alterations-in-bevacizumab-treated-early-onset-colorectal-cancer-an-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-targeted-phosphoproteomic-assay-to-enable-the-prediction-of-response-to-intensive-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olanzapine-for-weight-gain-in-children-undergoing-chemotherapy-for-solid-organ-malignancies-an-inve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-dietary-drivers-of-colorectal-cancer-mortality-in-the-united-states-a-33-year-global-burde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-functional-survivorship-in-oral-cavity-cancer-quality-of-life-qol-outcomes-by-return-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-primary-and-metastatic-tumor-informed-clonal-tracking-for-mrd-assessment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maternal-and-neonatal-complications-associated-with-breast-cancer-systemic-treatments-a-vigibase-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/universal-adipogenic-and-immunologic-remodeling-in-the-recurrent-myeloid-leukemia-microenvironment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-genomic-and-clinical-high-risk-features-on-outcomes-after-bcma-directed-bispecific-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measurable-residual-disease-mrd-by-circulating-tumor-ct-dna-in-patients-pt-with-rr-follicular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-fluoropyrimidine-cardiotoxicity-using-a-focus-beyond-routine-cardiovascular-risk-assessme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-safety-of-l-annamycin-at-high-cumulative-anthracycline-exposure-pooled-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dexamethasone-free-antiemetic-prophylaxis-with-olanzapine-in-children-and-adolescents-receiving-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dermatologic-adverse-events-daes-and-emotional-quality-of-life-qol-in-patients-pts-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-immunologic-vs-progenitor-landscapes-in-myeloid-leukemia-recurrence-adaptive-immune-persis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-related-adverse-events-cvd-aes-and-echocardiographic-echo-changes-with-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-neck-radiation-therapy-rt-in-combination-with-lenvatinibpembrolizumab-lp-in-braf-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-placebo-controlled-randomized-controlled-trial-using-combination-therapy-for-treatment-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-ml-based-prediction-of-fatal-immune-checkpoint-inhibitor-ici-associated-myocard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-perioperative-anlotinib-combined-with-cisplatin-and-doxorubicin-in-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protract-a-randomized-phase-ii-trial-comparing-ctdna-guided-biomarker-directed-therapy-vs-patientc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccl3-supsup-neutrophil-signature-as-a-predictor-of-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-baseline-testosterone-t-level-with-survival-outcomes-in-patients-pts-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-palliative-care-use-among-hospitalized-cancer-patients-a-seven-year-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-equol-producing-and-beta-glucuronidating-gut-bacteria-in-breast-cancer-using-16s-rdna-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-tumor-lysis-syndrome-in-non-hodgkin-lymphoma-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-myeloma-therapy-utilization-in-digital-health-advocacy-users-a-large-us-cohort-analysis-of-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avatrombopag-for-chemotherapy-induced-thrombocytopenia-in-gastrointestinal-malignancies-act-gi-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-pharmacokinetic-analysis-of-raludotatug-deruxtecan-r-dxd-a-cadherin-6-cdh6-directed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nimotuzumab-combined-with-concurrent-chemoradiotherapy-for-patients-with-postoperative-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-as-first-line-therapy-for-alk-positive-advanced-non-small-cell-lung-cancer-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-eligibility-screening-for-adjuvant-cdk46-inhibitors-in-high-risk-hrher2-early-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-barriers-to-cancer-clinical-trial-participation-at-an-urban-inner-city-safety-net-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-gut-microbiome-and-metabolomic-profiles-associated-with-durable-response-to-first-line-thir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-trials-to-the-clinic-real-world-experience-with-mirvetuximab-soravtansine-in-platinum-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ikrasi-sub-mutations-in-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-genomic-risk-and-treatment-gaps-in-black-patients-with-hr-early-breast-cancer-a-mammaprin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/driving-efficiency-in-oncology-care-tactical-solutions-for-inpatient-flow-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/occult-neoplasia-in-risk-reducing-bilateral-salpingo-oophorectomy-pathological-findings-and-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-yield-of-three-models-to-evaluate-germline-genetic-risk-in-patients-pts-with-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-spectrum-of-bevacizumab-induced-renal-injury-a-systematic-review-of-published-case-reports 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-arrhythmia-related-mortality-among-older-adults-with-cancer-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fluoropyrimidine-related-cardiotoxicity-in-patients-with-idpydi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-adjuvant-anlotinib-for-esophageal-squamous-cell-carcinoma-with-residual-disease-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-weekend-effect-in-spontaneous-tumor-lysis-syndrome-in-patients-with-hematological-malignancy-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bnt326-01-a-phase-1b2-trial-of-bnt326yl202-her3-adc-as-monotherapy-and-in-combination-with-pumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-germline-genetic-testing-in-prostate-pancreatic-and-ovarian-cancer-in-a-rural-setti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-xaluritamig-a-steap1-x-cd3-t-cell-engager-in-pediatric-adolescent-and-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escalating-site-burden-and-cost-whats-driving-the-surge-in-oncology-investigator-grants-over-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-tmab-plus-chemotherapy-ct-vs-ct-alone-in-the-perioperative-treatment-of-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-over-18-months-in-the-utilization-of-ctdna-monitoring-assays-for-solid-tumor-patients-in-us-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinicopathological-factors-impacting-survival-in-malignant-carcinoid-tumors-a-seer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-second-round-prrt-in-patients-with-progressive-refractory-stage-iv-neuroendocrine-neopla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bnt324-03-phase-3-randomized-open-label-trial-of-bnt324db-1311-a-b7h3-adc-versus-docetaxel-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-utilization-sequencing-patterns-and-healthcare-resource-utilization-in-walden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signal-er-101-signatera-guided-cdk46-inhibitor-therapy-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-cognitive-effects-of-avapritinib-towards-a-mechanistic-understanding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanistic-evaluation-of-thymol-in-a-rat-model-of-methotrexate-induced-intestinal-injury-nf-kb-nr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trofuse-036gog-3123engot-cx22-a-2-part-phase-3-randomized-study-of-sacituzumab-tirumotecan-sac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-neoadjuvant-zanzalintinib-zanza-plus-nivolumab-nivo-in-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-corticosteroid-and-tocilizumab-use-on-infection-incidence-and-outcomes-following-car-t-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-risk-factors-for-polyneuropathy-in-patients-receiving-immune-checkpoint-inhibitor-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-substance-use-disorder-on-pneumonia-hospital-outcomes-in-chronic-lymphocytic-leukemia-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/network-meta-analysis-of-first-line-therapies-for-unresectable-her2-negative-gastricgastroesophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-multidisciplinary-committee-within-a-national-oncology-society-an-educational-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-vs-nivolumab-plus-chemotherapy-in-metastatic-gastric-cancer-trinetx-propensity-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-economic-and-clinical-impact-of-lung-cancer-patient-support-programs-lc-psp-using-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alignment-of-vietnams-national-essential-medicines-list-with-cancer-incidence-and-the-who-eml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-brain-mri-surveillance-in-stage-iv-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-study-to-evaluate-the-safety-and-tolerability-activity-and-pk-of-a-potential-novel-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-expansion-of-a-phase-i-study-of-pln-101095-a-first-in-class-dual-a-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stromal-remodeling-and-neoantigen-clonality-as-used-to-evaluate-benefit-from-sirt-nivolumab-in-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-open-label-dose-escalation-and-expansion-study-of-gamitrinib-a-first-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-acceptance-of-trained-scent-detection-dogs-for-postoperative-surveillance-among-cancer-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-chemotherapy-on-survival-in-women-aged-70-with-hr-positive-her2-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-i-inrg1i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-image-guided-alpha-particle-therapy-study-of-sup203sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-physician-perspectives-on-neoadjuvant-immunotherapy-and-chemotherapy-in-early-stage-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-genotoxic-and-tumorigenic-potential-of-artificial-food-dyes-and-implications-for-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-saving-analysis-of-neoadjuvant-versus-adjuvant-immunotherapy-in-clinical-stage-iii-melanoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opioid-prescribing-in-cancer-patients-compared-with-non-cancer-patients-over-two-decades-2000-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-efbemalenograstim-alfa-versus-peg-rhg-csf-in-preventing-neutropenia-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-different-induction-chemotherapy-regimens-in-pediatric-and-adolescent-patients-with-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancies-spm-risk-after-car-t-cell-therapy-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-omentectomy-with-reduced-therapeutic-efficacy-of-lenvatinib-plus-pembrolizumab-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-characteristics-and-outcomes-in-platinum-resistant-ovarian-cancer-proc-patients-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bevacizumab-plus-trifluridinetipiracil-and-irinotecan-as-second-line-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-pet-ct-in-the-management-of-colorectal-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-immunogenomic-characteristics-of-ikrasi-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-sociodemographic-factors-and-healthcare-utilization-of-immune-related-adverse-even 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-assess-the-safety-and-efficacy-of-bomedemstat-img-7289-in-combination-with-mome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-study-of-the-treatment-journey-following-antibody-drug-conjugate-adc-initiation-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-on-the-management-of-post-mastectomy-lymphedema-in-breast-cancer-patients-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-after-metastatic-recurrence-following-perioperative-chemoimmunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypercalcemia-as-a-marker-of-in-hospital-mortality-and-resource-utilization-in-breast-cancer-a-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delays-in-receipt-of-neoadjuvant-chemotherapy-in-patients-with-localized-muscle-invasive-bladder-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-d842v-platelet-derived-growth-factor-alpha-pdgfra-mutant-gastrointestinal-stromal-tumours-gis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-chemo-immunotherapy-in-triple-negative-breast-cancer-at-a-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-adjuvant-pembrolizumab-in-resected-stage-iii-melanoma-real-world-evidence-from-a-peruvian-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ovarian-cancer-and-hypertension-changes-in-comorbidity-related-mortality-among-us-women-aged-45 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-patients-with-metastatic-melanoma-treated-with-sequential-metronomic-tem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-presentation-management-strategies-and-recurrence-rates-in-vulvar-intraepithelial-neoplas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/awareness-of-breast-cancer-symptoms-and-risk-factors-among-urban-delhi-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/orbital-cancer-historical-trends-in-histological-composition-and-cause-specific-mortality-based-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtypes-and-lymph-node-metastasis-in-endometrial-cancer-an-updated-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-and-the-patient-experience-in-rural-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-knowledge-and-willingness-for-biospecimen-donation-at-prisma-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-and-survival-in-hormone-receptor-positiveher2-negative-early-breast-cancer-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-of-radiotherapy-based-treatment-strategies-for-esophageal-cancer-a-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-glucocorticoid-toxicity-index-assessing-corticosteroid-toxicity-in-patients-with-immune-related 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-characteristics-of-kaposi-sarcoma-related-hospitalizations-and-in-hospital-outcomes-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-self-administered-e-health-dietary-quality-dq-assessment-in-patients-pts-at-increased-heredita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tyrosine-kinase-inhibitors-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-all-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-factors-associated-with-early-combination-therapy-initiation-in-metastatic-hormone-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-pkpd-profiling-in-human-ex-vivo-tumor-slices-to-identify-exposure-limited-niches-driving-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-expression-in-a-molecularly-characterized-cohort-of-endometrial-carcinoma-results-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-post-neoadjuvant-trastuzumab-emtansine-to-benchmark-destiny-breast-05-and-11-eme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-cancer-immunotherapy-for-p53-antibody-positive-non-small-cell-lung-cancer-according-to-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emiltatug-ledadotin-emi-le-a-b7-h4-directed-antibody-drug-conjugate-adc-in-patients-with-aggre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-dose-optimization-study-for-alveltamig-zg006-a-trispecific-t-cell-engager-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/checkmate-9dw-4-year-follow-up-overall-survival-by-depth-of-response-and-outcomes-in-long-term-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/farnesyl-transferase-inhibitor-fti-darlifarnib-ko-2806-in-combination-with-adagrasib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-response-and-outcomes-in-patients-with-myeloproliferative-neoplasms-treated-with-interfero 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-colorectal-cancer-among-adults-with-diabetes-mellitus-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-proliferation-immune-cell-infiltration-and-survival-outcomes-in-sarcomas-with-high-cancer-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-cadonilimab-ak104-in-locally-advanced-msi-hdmmr-gastric-or-gastroesophageal-junctio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bacillus-calmette-guerin-bcg-and-beyond-is-systemic-immunotherapy-for-bcg-naive-non-muscle-invasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-dendritic-cell-dc1-therapy-prior-to-neoadjuvant-chemotherapy-in-her2-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/majestec-9-a-phase-3-randomized-study-of-teclistamab-monotherapy-vs-investigators-choice-of-pomali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-of-trastuzumab-rezetecan-vs-standard-of-care-soc-for-chemotherapy-refractory-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-immune-related-toxicities-and-survival-in-non-small-cell-lung-cancer-treated-with-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-folfirinox-versus-gemcitabine-based-regimens-in-locally-advanced-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-supplement-use-among-adult-cancer-survivors-results-from-a-large-cross-sectional-study-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-metastatic-site-and-survival-in-non-small-cell-lung-cancer-a-seer-based-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-nadir-stratified-outcomes-of-arpi-doublet-and-docetaxel-triplet-therapy-in-metastatic-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-tmb-characterizing-tumor-intrinsic-genomic-architectures-of-immune-resistance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-mimicry-of-the-top1-cleavage-complex-by-intratumoural-bacterial-proteins-as-a-possible-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-of-high-risk-breast-cancer-patients-a-retrospective-descri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-the-next-generation-nectin-4-targeting-antibody-drug-conjugate-crb-701-sys6002 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-arterial-chemotherapy-for-retinoblastoma-treatment-outcomes-and-globe-preservation-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-reduction-in-intraoperative-frozen-sections-on-positive-margin-findings-in-the-final-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-concurrent-intrathecal-toripalimab-and-pemetrexed-pm-for-leptomeningeal-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-a-multimodal-tcrbcr-repertoire-foundation-model-on-blood-rna-seq-based-prediction-of-sev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-and-the-sequence-relative-to-survival-outcomes-in-sclc-analysis-of-the-national-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eif4b-expression-in-lung-squamous-cell-carcinoma-using-bulk-and-single-cell-transcriptomic-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-bo-among-oncology-professionals-in-the-middle-east-and-north-africa-mena-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-to-evaluate-the-safety-and-efficacy-of-bb-1701-in-combination-with-sintilimab-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lambert-eaton-myasthenic-syndrome-in-united-states-veterans-with-small-cell-lung-carcinoma-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-assessment-of-tumor-shedding-using-ai-derived-radiographic-tumor-burden-and-quantified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-progression-and-ai-based-prognostic-modeling-in-metastatic-nsclc-treated-with-chemo-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-proteomics-to-identify-biomarkers-for-the-diagnosis-and-prediction-of-leptomenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-with-brentuximab-vedotin-in-vitro-and-car-t-cell-function-and-viability-implications-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metformin-on-outcomes-with-immune-checkpoint-inhibitors-in-renal-cell-carcinoma-a-large-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-matched-ctdna-and-tissue-from-patients-with-four-common-cancers-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-analysis-of-car-t-cell-toxicities-target-antigens-and-dosing-in-solid-and-hematologi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immunotherapy-in-older-adults-with-advanced-nsclc-a-retrospective-cohort-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-score-tool-effectiveness-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-pet-ct-and-tumor-biology-for-pathological-complete-response-in-triple-negative-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-patients-with-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-pancreatic-ductal-adenocarcinoma-pdac-with-a-multiomic-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-impact-of-itp53i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-fractionated-stereotactic-radiotherapy-followed-by-surgical-resection-for-brain-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-digital-health-intervention-to-enhance-well-being-among-adolescent-and-young-adult-survivors-of-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-trends-in-early-stage-non-small-cell-lung-cancer-diagnosis-and-disparities-2018-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-treatment-patterns-social-determinants-of-health-and-safety-in-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-durvalumab-and-safety-by-treatment-period-in-matterhorn-a-randomized-phase-3-study-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fovinaciclib-versus-placebo-combined-with-fulvestrant-for-advanced-breast-cancer-after-endocrine-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-analysis-of-adoptive-neoantigen-specific-t-cell-immunotherapy-for-mgmt-unmethylated-glioblas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-docetaxel-d-ramucirumab-r-and-pembrolizumab-p-for-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-furmonertinib-in-iegfri-mutated-advanced-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrapatient-comparative-analysis-of-tumor-informed-ctdna-and-cthpv-dna-in-patients-with-hpv-driven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-outcomes-by-treatment-free-interval-among-patients-receiving-palbociclib-plus-endocrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-related-outcomes-associated-with-radioligand-therapy-in-prostate-cancer-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-proton-pump-inhibitor-use-with-cancer-specific-mortality-in-a-nationally-representati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevention-of-paclitaxel-induced-neurotoxicity-with-lithium-results-from-a-multicenter-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-with-resectable-early-stage-non-small-cell-lung-cancer-treated-with-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-large-language-models-for-multimodal-prediction-of-homologous-recombination-deficiency-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-broadening-trial-eligibility-criteria-on-the-inclusion-of-patients-infected-with-hiv-in-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-prognostic-scores-in-hispanic-patients-with-advanced-solid-tumors-enrolled-in-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-t-bren-bl-m07d1-monotherapy-or-in-combination-with-pertuzumab-in-patients-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-lenvatinib-beyond-immunotherapy-progression-in-endometrial-cancer-a-real-world-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-organ-adjacent-extracellular-vesicle-proteomics-from-uterine-lavage-on-accurate-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-circulating-tumor-dna-detection-and-molecular-clearance-as-a-prognostic-and-predictiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-a-digital-patient-directed-consent-process-for-msk-impact-tumor-normal-genetic-tes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-tumor-growth-models-to-improve-late-stage-lung-cancer-outcome-prediction-using-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-endocrine-therapy-omission-in-er-positive-breast-cancer-treated-with-neoadjuvant-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-from-the-phase-12-linker-al2-trial-of-linvoseltamab-linvo-in-patients-pts-with-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetes-risk-reduction-diet-and-mortality-outcomes-following-breast-cancer-diagnosis-in-black-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-immunotherapy-use-and-survival-outcomes-by-metastatic-pattern-in-metastatic-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-of-a-phase-1-dose-exploration-and-expansion-study-of-xaluritamig-plus-abiraterone-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pfs2-outcomes-by-prior-therapy-from-dreamm-8-a-phase-3-study-assessing-belantamab-mafodotin-belama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complex-segmentectomy-versus-lobectomy-in-small-sized-peripheral-non-small-cell-lung-cancer-a-post 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-post-discharge-home-care-for-reducing-potentially-avoidable-readmissions-in-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-resource-use-and-cost-in-patients-treated-with-originator-or-biosimilar-rituximab-in-a-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ql1706-pd-1ctla-4-bispecific-antibody-plus-bevacizumab-specific-for-patients-with-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extrachromosomal-dna-as-a-shaper-of-aggressive-transcriptional-states-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-stratification-of-early-stage-nsclc-patients-using-preoperative-circulating-tumor-dna-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-pk-assessment-of-revumenib-in-patients-with-relapsedrefractory-rr-acute-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-biomarkers-in-retroperitoneal-dedifferentiated-liposarcoma-and-their-clinical-impact-on-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-germline-pathogenic-variants-pvs-in-cancer-predisposition-genes-among-uns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-and-etiologic-heterogeneity-of-liver-cancer-in-the-united-states-a-comprehensive-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-patients-with-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ikrasi-mutant-circulating-tumor-dna-as-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnicity-based-comparative-analysis-of-treatment-endpoints-of-30000-hrher2-metastatic-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pemivibart-for-prevention-of-covid-19-subset-analysis-of-canopy-participants-with-solid-tumor-or-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-in-first-in-human-chemotherapy-free-combination-immunotherapy-targeting-lymphopenia-in-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-hospital-and-racial-disparities-in-surgical-treatment-and-mortality-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-toxicity-and-safety-profile-of-mirvetuximab-soravtansine-in-ovarian-cancer-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-real-world-study-of-irinotecan-liposome-ii-based-combination-regimens-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-decades-of-landscape-change-in-the-treatment-of-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-nal-iri5-fulv-benmelstobart-anlotinib-with-or-without-immunoradiotherapy-for-second-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-bermuda-model-achieving-world-class-equitable-and-efficient-cancer-care-in-a-small-island-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fair-inclusion-in-clinical-trials-updated-good-pharma-scorecard-evaluations-of-fda-oncology-drugs-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-secn-15-a-neuropilin-1-targeting-antisense-oligonucleotide-on-resistance-to-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/il7-il15-fusion-cytokine-fusokine-secreting-ipsc-derived-mesenchymal-stromal-cells-to-convert-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-survival-outcomes-of-quemliclustat-in-first-line-metastatic-pancreatic-ductal-adenocarc 2026-08-24 monthly 0.7